APLS FY 2017 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$2B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$51M

Operating Income

-$51M

Net Income

-$51M

EPS (Diluted)

$-1.49

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$47M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$182M

Total Liabilities

$33M

Stockholders' Equity

$149M

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$51M	$0	—
Operating Income	-$51M	-$27M	-86.1%
Net Income	-$51M	-$27M	-88.0%